A review of the clinical utility of the Enhanced Liver Fibrosis test in multiple aetiologies of chronic liver disease

Ann Clin Biochem. 2020 Jan;57(1):36-43. doi: 10.1177/0004563219879962. Epub 2019 Oct 17.

Authors

Preya Janubhai Patel¹, Declan Connoley^{1

2}, Freya Rhodes¹, Ankur Srivastava^{1

3}, William Rosenberg¹

Affiliations

¹ The Institute for Liver and Digestive Health, UCL Division of Medicine, UCL, London, UK.
² Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
³ Department of Gastroenterology & Hepatology, Southmead Hospital, North Bristol Trust, Bristol, UK.

PMID: 31529981
DOI: 10.1177/0004563219879962

No abstract available

Keywords: Enhanced Liver Fibrosis test; Liver fibrosis; alcoholic liver disease; hepatitis C; non-invasive test.

Publication types

Review

MeSH terms

Biomarkers / blood
Chronic Disease
Humans
Hyaluronic Acid / blood
Liver Diseases / diagnosis*
Liver Diseases / metabolism
Liver Function Tests / methods*
Peptide Fragments / blood
Procollagen / blood
Tissue Inhibitor of Metalloproteinase-1 / blood

Substances

Biomarkers
Peptide Fragments
Procollagen
TIMP1 protein, human
Tissue Inhibitor of Metalloproteinase-1
procollagen Type III-N-terminal peptide
Hyaluronic Acid